针治疗对缓解急性阶段中风住院患者的便秘的影响:一项随机对照试验
Hsiao-Chi Nieh1, Pi-O Wu1, Shiang-Ferng Ou1
1Department of Nursing, Veterans General Hospital, 1650 Taiwan Boulevard Sect. 4, Taichung, 40705, Taiwan, ROC.
Complementary therapies in clinical practice
|October 4, 2023
概括
针治疗有效地缓解了中风患者的便秘. 这种疗法减少了药物需求,并改善了神经科病房住院患者的肠道运动.
科学领域:
- 神经学 神经学
- 综合医学是一个整体的医学.
- 胃肠病学 胃肠病学
背景情况:
- 便秘是进入神经病科的中风患者常见的并发症.
- 便秘的有效管理对于患者的康复和舒适至关重要.
研究的目的:
- 研究针治疗治疗中风住院患者便秘的疗效.
- 在一个随机对照试验中,将针与假针进行比较.
主要方法:
- 一个随机对照试验,涉及128名中风住院患者,持续7天.
- 参与者每天接受两次针治疗 (ST25,CV12,CV6) 或假针治疗4分钟.
- 使用布里斯托尔便形状尺度和便秘评估尺度 (CAS) 评估便秘.
主要成果:
- 与假药组相比,针治疗组随着时间的推移显示出明显较低的CAS分数.
- 针治疗患者需要更少的药物来排便.
- 接受针治疗的患者经历了更正常的肠道运动和减少硬便.
结论:
- 基于传统中医的针治疗提供了一种可行的非药物治疗方法,以缓解中风住院患者的便秘.
- 针可以减少对药物的依赖,以控制这种患者群体的便秘.
更多相关视频
04:04Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
454
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
1.5K
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
01:21Drugs for Treatment of Constipation-Predominant IBS
188
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
188